NCT04181567
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Disease Attributes, +6 more
- Locations
-
- Kaohsiung Municipal Kai-Syuan Psychiatric Hospital Kaohsiung City, Taiwan
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,312 public trials
521 recruiting studies
Recurrence trial results
NCT04177316
- Conditions
- Disease Attributes, Hepatocellular Carcinoma Resectable, Pathologic Processes, +2 more
- Locations
-
- Ming-Chin Yu Taoyuan, Taiwan
NCT01065571
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +11 more
- Locations
-
- University of Illinois at Chicago Chicago, Illinois, United States
- University of Chicago Chicago, Illinois, United States
NCT01197560
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Providence St Joseph Medical Center/Cancer Center Burbank, California, United States
- MD Anderson Cancer Center Orlando Orlando, Florida, United States
- Emory University Atlanta, Georgia, United States
- Northwestern University Chicago, Illinois, United States
NCT02189343
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +18 more
- Locations
-
- UT Southwestern Medical Center Simmons Comprehensive Cancer Center Dallas, Texas, United States
- CTRC at The UT Health Science Center at San Antonio San Antonio, Texas, United States
- University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States
Completed
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
NCT03715660
- Conditions
- Bladder Cancer, Carcinoma, Disease Attributes, +18 more
- Locations
-
- Urology and Nephrology Center Al Mansurah, Egypt
NCT00948207
- Conditions
- Disease Attributes, Metastatic Cancer, Neoplasm Metastasis, +5 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
NCT01324947
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Royal Adelaide Hospital - SA Pathology Haematology Adelaide, Australia
- Princess Alexandra Hospital - Haematology Brisbane, Australia
- Royal Prince Alfred Hospital - Institute of Haematology Camperdown, Australia
- Peter McCallum Cancer Institute - Directorate of Cancer Medicine East Melbourne, Australia
NCT02290431
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kashiwa, Chiba, Japan
- Novartis Investigative Site Matsuyama, Ehime, Japan
- Novartis Investigative Site Fukuoka, Japan
Completed
LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT02652871
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States